z-logo
open-access-imgOpen Access
Circulating Prostate Tumor Cells Detected by Reverse Transcription-PCR in Men with Localized or Castration-Refractory Prostate Cancer: Concordance with CellSearch Assay and Association with Bone Metastases and with Survival
Author(s) -
Pauliina Helo,
Angel M. Cronin,
Daniel C. Danila,
Sven Wenske,
Rita Gonzalez-Espinoza,
Aseem Anand,
Michael Koscuiszka,
RiinaMinna Väänänen,
Kim Pettersson,
Felix K.H. Chun,
Thomas Steuber,
Hartwig Huland,
Bertrand Guillonneau,
James A. Eastham,
Peter T. Scardino,
Martin Fleisher,
Howard I. Scher,
Hans Lilja
Publication year - 2009
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2008.117952
Subject(s) - concordance , prostate cancer , medicine , oncology , prostate , cancer , pathology
Reverse transcription-PCR (RT-PCR) assays have been used for analysis of circulating tumor cells (CTCs), but their clinical value has yet to be established. We assessed men with localized prostate cancer or castration-refractory prostate cancer (CRPC) for CTCs via real-time RT-PCR assays for KLK3 [kallikrein-related peptidase 3; i.e., prostate-specific antigen (PSA)] and KLK2 mRNAs. We also assessed the association of CTCs with disease characteristics and survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom